An interventional study of HomeCare in Dementia and Alzheimer's Disease and Related Dementias, sponsored by HiDO Technologies. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by HiDO Technologies · Not applicable, Interventional, and Treatment
This study will evaluate whether the HomeCare medication management system can improve medication adherence and related outcomes for adults age 65 and older living with dementia, Alzheimer's disease, or related dementias.
HomeCare is an internet-connected medication management device that can automate medication dispensing, monitor medication use, and provide alerts to caregivers. The system is integrated with a Pharmacy Distribution System designed to track medications from pharmacy delivery through use in the home.
A total of 120 participants with dementia will be randomly assigned to one of two groups. One group will use the HomeCare system, while the other group will continue using standard medication management methods, such as pill bottles or blister packs. Participants will be followed for 12 months. The main outcome is medication adherence. The study will also examine hospitalizations and emergency room visits, cognitive function, caregiver burden, quality of life, satisfaction, and changes in medication-management behavior. Caregivers will also participate in surveys and study assessments. The study is intended to determine whether HomeCare can improve medication management and support both people living with dementia and their caregivers.
This is a two-arm randomized controlled trial evaluating the HomeCare Pharmacy Distribution System for medication management among adults living with dementia, Alzheimer's disease, or Alzheimer's disease-related dementias.
The study will enroll 120 participants with dementia and their caregivers. Participants will be randomized to either the HomeCare intervention group or a standard-care control group. Participants assigned to the intervention group will use the HomeCare system for medication management. The system is designed to automate medication dispensing, monitor medication adherence, document medication-use patterns, and provide real-time alerts to caregivers. Participants assigned to the control group will continue using traditional medication-management methods, including pill bottles or blister packs.
The primary objective is to evaluate medication adherence over 12 months. Medication adherence will be assessed using the Medication Adherence Rating Scale and Proportion of Days Covered, together with medication-use information collected through the HomeCare system for participants in the intervention group.
Additional outcomes will include hospitalizations and emergency room visits, cognitive function, caregiver burden, quality of life, satisfaction, and behavioral changes related to medication management. Cognitive function will be assessed using the Everyday Cognition assessment at baseline, 6 months, and 12 months. Caregiver burden and quality-of-life measures will also be collected during the study.
Caregivers in both study groups will receive study-related training and will complete surveys and other assessments related to caregiver burden, quality of life, medication-management activities, and their experience supporting the participant.
Participants will be age 65 or older and will have dementia, Alzheimer's disease, or a related dementia. The study will be conducted in collaboration with the University of California, Davis. Participants will be followed for 12 months. Study procedures include regular participant and caregiver follow-up, monitoring for device-related issues and adverse events, and collection of study outcome data.
Safety procedures include participant and caregiver training, regular study-team contact, secure handling of study data, and access to backup medication supplies if technical problems with the HomeCare device occur. Participants may withdraw from the study at any time.
2,230 studies on the registry are indexed under Dementia; 549 are open to participants now.
This study's planned enrollment of 120 is above the median of 83 across 1,669 interventional studies indexed under Dementia.
Browse Dementia studies →HiDO Technologies is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this arm will use the HomeCare system for medication management. The HomeCare system automates medication reminders, records medication intake, and provides caregivers with real-time alerts about adherence and patient behaviors. The system integrates medication dispensing, adherence monitoring, Video Directly Observed Therapy (VDOT), intervention support, and prescription information over the 12-month study period.
Device: HomeCare
Participants in this arm will follow the current standard of care for medication management using manual methods such as pill bottles or blister packs. Caregivers or participants will manually track medication adherence and manage medication schedules without technological assistance.
An automated, secure, AI driven medication delivery and observation platform to maximize therapy compliance, provide continuous medication monitoring and outcomes for individuals impacted by AD/ADRD.
Medication Adherence
Medication adherence will be assessed using the Medication Adherence Rating Scale (MARS) and Proportion of Days Covered (PDC). The HomeCare system will track adherence through its automated logging of medication usage and AI-powered monitoring algorithms.
Time frame: 12 months
Incidence of Hospitalizations
The frequency of hospitalizations and emergency room visits will be recorded and compared between the intervention and control groups.
Time frame: 12 months
ECOG Cognitive Assessment
The ECOG assessment will measure changes in cognitive function over the study period.
Time frame: Baseline, 6 months, 12 months
Zarit Burden Interview (ZBI) Score
Caregiver burden will be evaluated using the Zarit Burden Interview, a validated tool for assessing the psychological impact on caregivers.
Time frame: Baseline, 6 months, 12 months
Behavioral Changes in Medication Management
Assess the effectiveness of HomeCare's interventions (e.g., SMS notifications, video messages) on altering patient behavior regarding medication adherence.
Time frame: 12 months
EQ-5D-5L Health Questionnaire
The EQ-5D-5L will assess health-related quality of life for patients and caregivers.
Time frame: Baseline, 6 months, 12 months
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
HiDO Technologies